Close
Country websites:

CRRT fluids

Ci-Ca® Dialysate Plus solution bag

Solutions for cleaning the blood

  •  Consistent 5-liter bag format
  • Ready to use convenient handling
  • CRRT solutions 100% bicarbonate or lactate buffered

 

 

 

  • Key Features
  • Ci-Ca® Dialysate
  • multiBic®
  • multiPlus
  • Prescribing Information

Bicarbonate buffered CRRT solutions

multiBic® solution bag
multiBic® solution bag

*Depending on local product approval

Phosphate-containing CRRT solutions

Ci-Ca® Dialysate Plus solution bag
Ci-Ca® Dialysate Plus solution bag
  •  Ci-Ca® Dialysate Plus
  • multiPlus

During an effective CRRT treatment the removal of uremic toxins from patient’s blood is desirable, but important nutrients such as glucose and phosphate are also lost. To limit the loss of glucose, modern CRRT solutions contain a near physiological glucose concentration. Following the same principle, the negative results of an excessive phosphate loss can be avoided. multiPlus is an advanced CRRT solution containing a physiological phosphate concentration, that prevents excessive reduction of phosphate during CRRT treatment and thus prevents the formation of hypophosphatemia due to CRRT with its negative implications for the patients.

Ci-Ca® Dialysate K2 / K4

*Depending on local product approval

Ci-Ca® Dialysate Plus

multiBic® – Always the right solution

Sophisticated and convenient — The multiBic® 5 liter bag has many advantages

multiBic® at a glance

multiPlus – CRRT solution with phosphate

multiPlus solution bag
multiPlus solution bag

Preventing the formation of Hypophosphatemia

Abbreviated Prescribing Information for multiBic® solution

PDF , 52.7 KB

Abbreviated Prescribing Information for multiBic® solution

PDF , 52.7 KB

Abbreviated Prescribing Information for multiBic® solution

PDF , 52.7 KB

Downloads

Acute Dialysis Product Range

PDF , 2.0 MB

Acute Dialysis Product Range

PDF , 2.0 MB

Acute Dialysis Product Range

PDF , 2.0 MB

1 Amanzadeh J. & Reilly RF Jr., Nature Clinical Practice Nephrology (2006); 2: 136 - 148
2 Lentz R. et al., Annals of Internal Medicine (1978); 89: 941 - 944
3 Gatchalian R. et al., American Journal of Kidney Diseases (2000); 36: 1262 - 1266
4 Zazzo J. et al., Intensive Care Med (1995); 21: 826 - 831
5 Shor R. et al., Annals of Clinical & Laboratory Science (2006); 36: 67 - 72
6 Schwartz A. et al., European Journal of Internal Medicine (2002); 13: 434 - 438
7 Zazzo J. et al., Intensive Care Med (1995); 21: 826 - 831
8 Shor R. et al., Annals of Clinical & Laboratory Science (2006); 36: 67 - 72
9 Schwartz A. et al., European Journal of Internal Medicine (2002); 13: 434 - 438

Related Content